Technical Analysis for PEN - Penumbra, Inc.

Grade Last Price % Change Price Change
grade A 157.96 -1.34% -2.15
PEN closed down 1.34 percent on Friday, March 22, 2019, on 1.18 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical PEN trend table...

Date Alert Name Type % Chg
Mar 22 Multiple of Ten Bearish Other 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 NR7 Range Contraction -1.34%
Mar 21 NR7-2 Range Contraction -1.34%
Mar 21 Multiple of Ten Bullish Other -1.34%
Mar 21 Overbought Stochastic Strength -1.34%
Mar 21 Up 3 Days in a Row Strength -1.34%
Mar 20 NR7 Range Contraction 0.13%
Mar 20 Overbought Stochastic Strength 0.13%

Older signals for PEN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in United States, Japan, and internationally. The company offers neurovascular access products under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; and aspiration-based thrombectomy systems and accessory devices under the Penumbra System brand, as well as stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands, as well as neurovascular stents under the LIBERTY Stent brand; neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; detachable embolic coil systems for peripheral embolization under the RUBY Coil brand; detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand. The company sells its products through its salesforce and distributors to hospitals in the neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Medicine Health Health Care Interventional Radiology Stent Markets Medical Devices Aneurysm
Is PEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 167.35
52 Week Low 110.84
Average Volume 350,149
200-Day Moving Average 139.9716
50-Day Moving Average 144.6478
20-Day Moving Average 146.32
10-Day Moving Average 152.299
Average True Range 4.9987
ADX 21.8
+DI 35.089
-DI 17.3273
Chandelier Exit (Long, 3 ATRs ) 147.5039
Chandelier Exit (Short, 3 ATRs ) 139.8111
Upper Bollinger Band 162.3615
Lower Bollinger Band 130.2785
Percent B (%b) 0.86
BandWidth 21.926599
MACD Line 3.8908
MACD Signal Line 2.2981
MACD Histogram 1.5927
Fundamentals Value
Market Cap 5.34 Billion
Num Shares 33.8 Million
EPS 0.15
Price-to-Earnings (P/E) Ratio 1053.07
Price-to-Sales 11.15
Price-to-Book 8.79
PEG Ratio -71.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 164.97
Resistance 3 (R3) 165.70 164.10 163.80
Resistance 2 (R2) 164.10 162.32 163.73 163.41
Resistance 1 (R1) 161.03 161.21 160.23 160.30 163.02
Pivot Point 159.43 159.43 159.03 159.06 159.43
Support 1 (S1) 156.36 157.65 155.56 155.63 152.90
Support 2 (S2) 154.76 156.54 154.39 152.51
Support 3 (S3) 151.69 154.76 152.12
Support 4 (S4) 150.96